Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the results of recent clinical trials using US Food and Drug Administration–approved or investigational agents for the treatment of colorectal cancer
- Relate results from investigation of novel treatment options in hepatocellular carcinoma
- Summarize data regarding novel chemotherapeutic approaches and combined modality options for treatment of esophageal and gastric cancers
- Articulate status of use of targeted agents with chemotherapy for pancreatic cancer
CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.